We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-0.04%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$717M
AUM Growth
+$27.3M
Cap. Flow
+$32.6M
Cap. Flow %
4.54%
Top 10 Hldgs %
29.66%
Holding
2,758
New
211
Increased
1,430
Reduced
492
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 12.64%
2 Consumer Staples 8%
3 Financials 7.08%
4 Consumer Discretionary 6.44%
5 Healthcare 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BATRK icon
2501
Atlanta Braves Holdings Series B
BATRK
$3.25B
$0 ﹤0.01%
11
+6
+120% +$158
BE icon
2502
Bloom Energy
BE
$53.5B
$0 ﹤0.01%
10
+1
+11% +$21
BF.A icon
2503
Brown-Forman Class A
BF.A
$12.8B
$0 ﹤0.01%
6
-3
-33% -$200
BIPC icon
2504
Brookfield Infrastructure
BIPC
$5.03B
-14
Closed -$1K
BMI icon
2505
Badger Meter
BMI
$3.71B
-3
Closed
BNR
2506
Burning Rock Biotech
BNR
$99.1M
$0 ﹤0.01%
2
-2
-50% -$445
BOX icon
2507
Box
BOX
$4.18B
$0 ﹤0.01%
+10
New +$246
BRKL
2508
DELISTED
Brookline Bancorp
BRKL
-23
Closed
BSRR icon
2509
Sierra Bancorp
BSRR
$540M
$0 ﹤0.01%
+5
New +$122
BSY icon
2510
Bentley Systems
BSY
$10.2B
$0 ﹤0.01%
4
-49
-92% -$3.13K
BV icon
2511
BrightView Holdings
BV
$1.33B
$0 ﹤0.01%
+25
New +$381
CAC icon
2512
Camden National
CAC
$923M
-152
Closed -$7K
CASI
2513
DELISTED
CASI Pharmaceuticals
CASI
-27
Closed
CASS icon
2514
Cass Information Systems
CASS
$705M
$0 ﹤0.01%
+5
New +$213
CCCC icon
2515
C4 Therapeutics
CCCC
$397M
$0 ﹤0.01%
+4
New +$171
CCRN
2516
DELISTED
Cross Country Healthcare
CCRN
-13
Closed
CDLX icon
2517
Cardlytics
CDLX
$21.7M
0
CDNA icon
2518
CareDx
CDNA
$1.88B
-1
Closed
CERT icon
2519
Certara
CERT
$1.21B
-9
Closed
CEVA icon
2520
CEVA Inc
CEVA
$980M
-6
Closed
CFFN icon
2521
Capitol Federal Financial
CFFN
$1.07B
$0 ﹤0.01%
+33
New +$373
CG icon
2522
Carlyle Group
CG
$16.7B
$0 ﹤0.01%
+5
New +$240
CHEF icon
2523
Chefs' Warehouse
CHEF
$3.9B
-15
Closed
CHRS icon
2524
Coherus Oncology
CHRS
$225M
$0 ﹤0.01%
28
+10
+56% +$147
CRD.A icon
2525
Crawford & Co Class A
CRD.A
$545M
$0 ﹤0.01%
+51
New +$500

Similar funds

Quadrant Capital Group's Q3 2021 Portfolio in Review

As of Q3 2021, Quadrant Capital Group held 2,758 positions worth $717M, up 4% from $689M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $32.6M of net new capital in Q3 2021, opening 211 new positions and adding to 1,430 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 3,278 shares worth $85K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Hillenbrand, an estimated $571K trimmed.

  • Quadrant Capital Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 3,278 shares worth $85K.
  • Quadrant Capital Group added most to iShares Russell 1000 ETF in Q3 2021, an estimated $2.03M increase.
  • Quadrant Capital Group's biggest Q3 2021 reduction was Hillenbrand, cutting an estimated $571K.
  • Quadrant Capital Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $235K.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $717M portfolio in Q3 2021.
  • Quadrant Capital Group opened 211 new positions and closed 124 in Q3 2021.
  • Quadrant Capital Group's portfolio value rose 4% quarter-over-quarter to $717M.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.